Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR

MLA

Adalbert Krawczyk, et al. “Assessing the Risk of CMV Reactivation and Reconstitution of Antiviral Immune Response Post Bone Marrow Transplantation by the QuantiFERON-CMV-Assay and Real Time PCR.” Journal of Clinical Virology, Feb. 2018, pp. 61–66. EBSCOhost, https://doi.org/10.1016/j.jcv.2018.01.002.

APA

Adalbert Krawczyk, Markus Ditschkowski, Birgit Goitowski, Rudolf Trenschel, Nico Grüner, Jessica Ackermann, Hellmut Ottinger, Jörg Timm, Dietrich W. Beelen, & Melanie Fiedler. (2018). Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR. Journal of Clinical Virology, 61–66. https://doi.org/10.1016/j.jcv.2018.01.002

Chicago

Adalbert Krawczyk, Markus Ditschkowski, Birgit Goitowski, Rudolf Trenschel, Nico Grüner, Jessica Ackermann, Hellmut Ottinger, Jörg Timm, Dietrich W. Beelen, and Melanie Fiedler. 2018. “Assessing the Risk of CMV Reactivation and Reconstitution of Antiviral Immune Response Post Bone Marrow Transplantation by the QuantiFERON-CMV-Assay and Real Time PCR.” Journal of Clinical Virology, February, 61–66. doi:10.1016/j.jcv.2018.01.002.